(Q46884463)

English

A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.

scientific article published on 7 April 2005

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Emily R Nolan

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

Meihua Rose Feng

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

Jeffrey R Koup

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

Jing Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

Daniel Turluck

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

Yiqun Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

Jerome B Paulissen

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

N Bari Olivier

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

Teresa Miller

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

Marc B Bailie

10

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

publication date

7 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

Journal of Pharmacological and Toxicological Methods

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

53

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

1-10

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

Arrhythmogenic mechanisms of QT prolonging drugs: is QT prolongation really the problem?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Comparison of formulae for heart rate correction of QT interval in exercise electrocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Diurnal variation of the QT interval--influence of the autonomic nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Idiopathic long QT syndrome with late onset of bradycardia-dependent and short-coupled variant of torsade de pointes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Pharmacokinetics and pharmacodynamics of cisapride in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Effects of H1 antihistamines on animal models of QTc prolongation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Heart rate--QT relationships during baroreceptor stimulation with diminished autonomic influence on the ventricles. Ventricular autonomic tone and QT interval

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Autonomic nervous system influences on QT interval in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Problems of heart rate correction in assessment of drug-induced QT interval prolongation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Drug interactions with cisapride: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Atrioventricular nodal ablation and His-bundle pacing: an acute canine model for proarrhythmic risk assesment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Safety pharmacology--a progressive approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Drug-induced prolongation of the QT interval

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Stability of ventricular repolarization in conscious dogs with chronic atrioventricular dissociation and his-bundle pacing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Simultaneous assessment of the hemodynamic, cardiomechanical, and electrophysiological effects of terfenadine on the in vivo canine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2005.02.003

7 January 2021

Identifiers

10.1016/J.VASCN.2005.02.003

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16399550

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46884463&oldid=2144543988"